CoreSite Realty Corporation (COR)
$336.36
$5.39
(1.63%)
As on 02-Sep-2026 16:17EDT
Market cap
$60,051 Mln
Revenue (TTM)
$332,771 Mln
P/E Ratio
23.5
P/B Ratio
19.8
Div. Yield
0.7 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$220 Mln
-
ROE
1 %
-
ROCE
-- %
-
Industry P/E
31.06
-
EV/EBITDA
13.4
-
Debt to Equity
3.8
-
Book Value
$--
-
EPS
$13.5
-
Face value
--
-
Shares outstanding
190,827,165
10 Years Aggregate
CFO
$26,795.61 Mln
EBITDA
$17,941.68 Mln
Net Profit
$3,142.60 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CoreSite Realty Corporation (COR)
| -0.4 | 8.0 | 27.1 | 15.3 | 24.3 | 22.4 | 14.5 |
|
BSE Sensex*
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Midcap 400
| 11.9 | -0.3 | 0.8 | 15.1 | 12.0 | 6.3 | 9.1 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
CoreSite Realty Corporation (COR)
| 50.3 | 9.3 | 23.9 | 40.2 | 16.5 | 34.1 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
CoreSite Realty Corporation (COR)
|
336.4 | 60,051.4 | 332,771.3 | 2,624.8 | 1.2 | 105.3 | 23.5 | 19.8 |
| 172.9 | 81,915.8 | 10,942.0 | 3,378.6 | 45.1 | 89.1 | 24.1 | 22.0 | |
| 183.8 | 73,193.0 | 6,848.8 | 799.0 | 20.6 | 3.2 | 242.9 | 2.7 | |
| 139.9 | 32,500.7 | 3,426.2 | 957.8 | 71.0 | 6.9 | 32.7 | 2.4 | |
| 111.9 | 36,325.7 | 7,562.5 | 418.7 | 19.3 | -- | 86.5 | 1,516.5 | |
| 301.3 | 60,270.3 | 4,890.5 | 2,044.4 | 45.3 | 22 | 31.1 | 12.5 | |
| 186.4 | 20,257.5 | 2,870.6 | 990.7 | 59.1 | -- | 20.6 | 91.0 | |
| 92.1 | 47,734.8 | 6,441.6 | 266.3 | 15.7 | 1.9 | 169.2 | 3.2 | |
| 238.6 | 172,375.2 | 12,612.7 | 1,346.0 | 4.1 | 2.9 | 107.3 | 3.7 | |
| 23.2 | 17,744.5 | 6,901.0 | 472.0 | 9.4 | 5 | 37.3 | 1.9 |
Shareholding Pattern
View DetailsAbout CoreSite Realty Corporation (COR)
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home... healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania. Read more
-
Chairman, President & CEO
Mr. Steven H. Collis
-
Executive Chairman
Mr. Steven H. Collis
-
Headquarters
Conshohocken, PA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for CoreSite Realty Corporation (COR)
What is the current share price of CoreSite Realty Corporation (COR) Today?
The share price of CoreSite Realty Corporation (COR) is $336.36 (NYSE) as of 02-Sep-2026 16:17 EDT. CoreSite Realty Corporation (COR) has given a return of 24.34% in the last 3 years.
What is the current PB & PE ratio of CoreSite Realty Corporation (COR)?
The P/E ratio of CoreSite Realty Corporation (COR) is 23.54 times as on 21-Aug-2026, a 24 discount to its peers’ median range of 31.06 times.
The P/B ratio of CoreSite Realty Corporation (COR) is 19.83 times as on 21-Aug-2026, a 990 premium to its peers’ median range of 1.82 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
38.99 |
40.18 |
2024 |
29.87 |
69.79 |
2023 |
20.97 |
70.12 |
2022 |
16.72 |
-134.29 |
2021 |
16.35 |
112.74 |
What is the 52 Week High and Low of CoreSite Realty Corporation (COR)?
The 52-week high and low of CoreSite Realty Corporation (COR) are Rs 377.54 and Rs 244.82 as of 03-Sep-2026.
What is the market cap of CoreSite Realty Corporation (COR)?
CoreSite Realty Corporation (COR) has a market capitalisation of $ 60,051 Mln as on 21-Aug-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in CoreSite Realty Corporation (COR)?
Before investing in CoreSite Realty Corporation (COR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.